Lindus Health's platform covers the entire clinical trial process, from initial trial design to data capture and analysis. The company's AI protocol tool, which is currently at the proof-of-concept stage, can generate a first draft protocol based on a small number of inputs, highlighting trial risks and suggesting improvements. The company's data capture system allows trial staff to capture all data electronically from the start, with AI used to monitor and manage the process and check for data completeness and accuracy.
Key takeaways:
- Lindus Health, a UK-based startup, has raised $18 million in a Series A funding round to streamline the process of running clinical trials. The company uses machine learning and AI to automate and improve various stages of the trial process.
- The company was founded in 2021 and has already delivered more than 80 clinical trials across Europe and North America, focusing on conditions such as depression, diabetes, and insomnia.
- Lindus Health aims to cover the entire end-to-end process of running clinical trials, differentiating itself from other tech-infused clinical trial companies that offer specific "point" solutions.
- Despite being a startup, Lindus Health aims to compete with big Contract Research Organizations (CROs) in the $77 billion CRO market. The company's goal is to make clinical trials more scalable and efficient.